Blog
What Are Adaptive Trial Statistics? Benefits, Methods, and Applications
A trial designed in year one doesn’t have to run exactly the same way in year three. That premise sits underneath adaptive design as a whole. Fixed trials lock their
Clinical Programming
Clinical Programming (Phases I–IV) – Site selection, patient recruitment, investigator oversight.
Regulatory Affairs
Regulatory Affairs – Submission planning, compliance with ICH-GCP, DCGI, and FDA norms.
Data Management
Data Management & Biostatistics – EDC systems, analysis, reporting, and clinical study documentation.
Weltrix
We Provide Reliable & High-Quality Clinical Service
Weltrix is a Clinical Research Organization (CRO) dedicated to advancing clinical research and accelerating the development of life-saving therapies for patients worldwide.
- Comprehensive Clinical Trial Solutions
- Innovation & Integrity
- Global Reach
Why Weltrix
Why Sponsors Choose Weltrix
- Tailored CRO services for small and mid-size biotech sponsors
- Smaller teams. Faster starts. Fewer handoffs
- Senior experts directly manage your trial — no hand-off to junior teams
- Agile, transparent, and proactive communication
- ICH-GCP-aligned execution and quality assurance
- Cost-effective for emerging biotech budgets
Our Services
We Provide Reliable Services
Statistical Programming
Condensate treatment is a crucial aspect of industrial process, particularly in systems.
Clinical Programming
After treatment, potable water is distribute through well maintained systems of pipes.
Working Process
Our Working Process
1
Define Study Needs
Client shares trial objectives and requirements.
2
Proposal & Plan
We outline timelines, deliverables, and approach.
3
Execute with Precision
Data management, stats programming, and biostatistics.
4
Submission-Ready O/P
High-quality reports, tables, and regulatory support.
Weltrix vs. Traditional Large CROs: A Side-by-Side Comparison
| Key Factor | Weltrix (New, Agile CRO) | Typical Large CRO |
|---|---|---|
| Client Focus | ✅ High-touch, personalized engagement — founders involved in delivery | ❌ Often impersonal; sponsors managed by rotating junior staff |
| Team Access | ✅ Direct access to senior experts and decision-makers | ❌ Layers of project managers and admin slow things down |
| Speed & Agility | ✅ Quick study start-up, flexible processes, faster responses | ❌ Bureaucratic workflows, slow onboarding, delayed timelines |
| Pricing | ✅ Cost-effective for emerging biotech budgets | ❌ Premium pricing; rigid pricing models |
| Process Flexibility | ✅ Adapts to sponsor tools, templates, and SOPs | ❌ Requires conformity to CRO’s own systems and processes |
| Therapeutic Specialization | ✅ Focused experience in key therapeutic areas (customize this per your expertise) | ❌ Often generalized across many areas, limited depth per project |
| Communication | ✅ Fast, transparent, proactive updates | ❌ Sponsors often left chasing updates; delayed escalations |
| Ownership & Accountability | ✅ Small team = high accountability & attention to detail | ❌ Large teams = diffusion of responsibility |
| Innovation | ✅ Open to new tech, tools, and trial designs | ❌ Slower to adopt innovative models unless enterprise-driven |
| Cultural Fit for Biotech | ✅ Built to support small and mid-size sponsors | ❌ Processes built around big pharma expectations |
Recent Posts
Blog
TLF Programming Best Practices for Clinical Study Reports
There are three aspects to getting your TLF programming right, you need locked-in statistical plans, repeatable templates, and hard independent verification. Phase III trials routinely throw up 200 to 500
Blog
AI-Powered Clinical Data Management: Benefits, Risks, and Future Trends
AI-powered clinical data management is transforming how pharmaceutical companies, contract research organizations (CROs), and healthcare institutions collect, process, validate, and analyze data across clinical trials. As the volume and complexity